Back to CVE records
High 7.1Published Oct 20, 2026

CVE-2026-101735Vulnerability in the Primavera Unifier product of Oracle Construction and Engineering (component: Project Control).

Updated under an hour ago ()

Does this affect you?

It affects Oracle Corporation Primavera Unifier. Add what you run to find out whether that includes you.

EPSS puts the chance of exploitation in the next 30 days at 0.26%, higher than 17% of scored CVEs.

Vulnerability in the Primavera Unifier product of Oracle Construction and Engineering (component: Project Control). Supported versions that are affected are 23.12.0-23.12.16. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Primavera Unifier. Successful attacks of this vulnerability can result in unauthorized creation, deletion or modification access to critical data or all Primavera Unifier accessible data as well as unauthorized read access to a subset of Primavera Unifier accessible data. CVSS 3.1 Base Score 7.1 (Confidentiality and Integrity impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:H/A:N).

CVSS
7.1 HIGH (v3.1, CNA)CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:H/A:N
Weakness (CWE)
CWE-284
Known exploited
Not in CISA's KEV catalog
EPSS (exploitation in the next 30 days)
0.26% (percentile 17)
Assigned by
oracle
NVD analysis
Awaiting Analysis
Record last updated
Oct 22, 2026
First seen by InfoSec Signals
Oct 20, 2026

Affected products

Affected products
Oracle Corporation Primavera Unifier
oracle:primavera_unifier (from the name)
from 23.12.0 through 23.12.16
CNA record

References

References

The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.

Your cookie choices
We use essential cookies to run this site, and, only with your consent, an advertising cookie from Google to measure whether our ads lead to sign-ups and subscriptions. See our for details.